Novo Nordisk appoints Valney Suzuki CEO for Mexico, effective 1 November
Novo Nordisk nombra a Valney Suzuki Director General para México, a contar desde el 1 de noviembre
Intel ID : 331783
|
||||
| Intel ID | 331783 | ||
| Value | ND | ||
| Native Currency |
Mexican Peso (MXN)
Exchange Rate:  |
||
| Date |
|
||
| Country | |
||
| Geography |  |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.05.05 Drug Stores & Pharmacies 15 Consumer Products & Services / 15.05 Distribution & Retail |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.